Oakdale, MN · Health Care · Form D filed Oct 14, 2026
InSitu Biologics, Inc. raised $1.3M
InSitu Biologics, Inc. is a biotechnology company based in Oakdale, Minnesota. In an amended Form D filed with the SEC on October 14, 2026, it reported raising $1,250,000 from 1 investor as part of an offering of up to $3,375,000. The first sale in the offering took place on August 4, 2026.
InSitu Biologics is advancing localized sustained-release drug delivery, starting with INSB200™, a peripheral nerve block for extended post-surgical pain relief.
- 7th Form D since 2017. Earlier new notices: Aug 10, 2026 · Dec 18, 2025 · Dec 29, 2023 · Feb 25, 2021 · Dec 7, 2017 · Nov 22, 2017. All filings on EDGAR
- Still raising. $2.1M of the $3.4M offering was still unsold at filing.
$13.2M raised since 2020
4 Form D offerings, as reported to the SEC, the first in Feb 25, 2021. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 10, 2026 | $1.3M | $3.4M | 1 |
| Dec 18, 2025 | $4M | $8M | 29 |
| Dec 29, 2023 | $3M | $3M | 1 |
| Feb 25, 2021 | $5M | $5.5M | 22 |
Lead score
39 out of 100
filed this week still raising budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- insitubiologics.com
- Amount raised
- $1,250,000
- Offering size
- $3,375,000
- Investors so far
- 1
- Minimum investment
- $2,500,000
- First sale
- August 4, 2026
- Securities offered
- Debt, Options or warrants, Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Oakdale, Minnesota
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D/A (amendment) | $1,250,000 | $3,375,000 | 1 | SEC filing | |
| D (new notice) | $1,250,000 | $2,500,000 | 1 | SEC filing |
Figures come from the company's own filings with the SEC and are shown as reported. The first notice for this offering was filed on August 10, 2026. How to read a Form D.
Updated · Raises in the week of Aug 10, 2026 · Health Care funding in Minnesota · August 2026 funding report
Similar raises
Surgicare of Minneapolis, Ltd.
St. Louis Park, MN · filed Oct 87th Form D since 2011
Vireo Growth Inc.
Minneapolis, MN · filed Oct 7
Vireo Growth, Inc.'s mission is to provide safe access, quality and value to its customers while supporting its communities through active participation and restorative justice programs. The Company…
17th Form D since 2019
Piraeus Medical, Inc.
Rochester, MN · filed Oct 7
11th Form D since 2022Still raising
Pelvital USA, Inc.
Eagan, MN · filed Oct 58th Form D since 2020Still raising
Evia Bio, Inc.
Minneapolis, MN · filed Sep 28
Evia Bio’s cryopreservation technology enables the entire Cell Therapy supply chain with high product yield, efficacy, and safety. You don’t have to settle for less.
First Form D
EyeMacular Regeneration, Inc.
St. Paul, MN · filed Sep 252nd Form D since 2024Still raising
ProEncia Biotechnology Inc.
Woodbury, MN · filed Aug 26First Form DStill raising
Pelva Health Corp
Edina, MN · filed Aug 72nd Form D since 2024Still raising